Long-Awaited PBM Reform Included in Congress’ End-of-Year Spending Package
Drug Topics
DECEMBER 18, 2024
The American Pharmacists Association announced the inclusion of pharmacist-backed PBM reform in Congress end of the year spending package.
Drug Topics
DECEMBER 18, 2024
The American Pharmacists Association announced the inclusion of pharmacist-backed PBM reform in Congress end of the year spending package.
Fierce Healthcare
DECEMBER 18, 2024
It still needs to pass, but an end-of-year package for healthcare is looking probable. The legislation includes PBM reform, telehealth extensions and more.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
DECEMBER 18, 2024
MannKind announced results from the INHALE-1 study that examined Afrezza in children and adolescents with diabetes.
Pharmacy Times
DECEMBER 18, 2024
The researchers suggest that an imbalance between pro-inflammatory and resolving lipid mediators may drive tumor growth.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare
DECEMBER 18, 2024
Health AI company Suki rolled out two new features to its Suki AI Assistant powered by Google Cloud. | Suki AI released new features Thursday that brings its technology closer to a general AI assistant for clinicians from just an ambient AI scribing tool. The company touts that it is the first to release a patient summarization and search feature.
Pharmacy Times
DECEMBER 18, 2024
Ustekinumab-stba (Steqeyma; Celltrion) is a subcutaneous treatment for adult and pediatric patients with plaque psoriasis arthritis, psoriatic arthritis, Crohn disease, and ulcerative colitis.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
pharmaphorum
DECEMBER 18, 2024
The FDA has started a review of MSD's RSV antibody clesrovimab, a potential rival to Beyfortus, with a verdict due in the middle of next year
Drug Topics
DECEMBER 18, 2024
Chelsee Jensen, PharmD, BCPS, senior pharmacy specialist at the Mayo Clinic, discusses her career and how biosimilars will impact the pharmacy profession in the coming years.
STAT
DECEMBER 18, 2024
Hello, everyone, and how are you today? We are doing just fine, thank you, especially since the middle of the week is upon us. After all, we have made it this far so we are determined to hang on for another couple of days. And why not? The alternatives — at least those we can identify — are not so appetizing. And what better way to make the time fly than to keep busy.
Drug Topics
DECEMBER 18, 2024
The patients symptoms gradually resolved after discontinuing fezolinetant therapy.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
STAT
DECEMBER 18, 2024
James Mannion knew what he needed. For nine months, while incarcerated in a county jail in Portland, Maine, he pleaded for a medication called buprenorphine. Mannion, a barber, recreational fisherman, and father of two, was once a regular heroin user, but had used the medication to eliminate the cravings and withdrawal he experienced whenever he tried to quit opioids cold turkey.
pharmaphorum
DECEMBER 18, 2024
SiteOne Therapeutics has completed a $100 million third-round financing that will support clinical trials of its non-opioid painkiller.
Pharmacy Times
DECEMBER 18, 2024
Ultra-processed food consumption fuels the rising rates of childhood obesity, diabetes, and liver disease, highlighting opportunities for pharmacist intervention.
Pharmaceutical Technology
DECEMBER 18, 2024
Abera and Orexo have entered a partnership to develop and test the powder formulations of the formers vaccine candidates.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmacy Times
DECEMBER 18, 2024
Pharmacists and health care providers can recommend healthy foods that are rich in choline and iodine if individuals are not receiving enough in prenatal vitamin supplements.
The Checkup by Singlecare
DECEMBER 18, 2024
Zyrtec ( cetirizine ) is an over-the-counter ( OTC ) medication and antihistamine used to treat allergy symptoms. Signs of allergic rhinitis, hay fever , and seasonal allergies include sneezing , runny nose , stuffy nose , swollen nasal passages , itchy eyes , and watery eyes. These conditions are similar to nonallergic rhinitis in that they cause the same symptoms, but they are different in that the latter isnt caused by contact with an allergen.
Pharmacy Times
DECEMBER 18, 2024
The updated prescribing information recommends laboratory tests prior to prescribing fezolinetant to determine baseline for hepatic function and injury.
Fierce Pharma
DECEMBER 18, 2024
Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. | Indian drugmakers Aurobindo, Glenmark and Zydus have issued separate sweeping drug recalls over issues pertaining to impurities and labeling. The product pulls were catalogued in a recent edition of the FDA's weekly enforcement report.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmacy Times
DECEMBER 18, 2024
If approved, cyclobenzaprine hydrochloride (HCl) will be the first member of a new class of analgesic drugs for fibromyalgia.
Fierce Healthcare
DECEMBER 18, 2024
Healthcare spending reached nearly $5 trillion in 2023, growing by 7.5% from the prior year, according to new data from the federal government. | Healthcare spending reached nearly $5 trillion in 2023, growing by 7.5% from the prior year, according to new data from the federal government.
Pharmacy Times
DECEMBER 18, 2024
Food insecurity in rural communities can affect hypertension, but pharmacists can mitigate the impact by educating themselves on nutrition options for low-income individuals.
Pharmaceutical Technology
DECEMBER 18, 2024
New hope for long-COVID patients: Longidaza boosts exercise tolerance and improves pulmonary function.
Pharmacy Times
DECEMBER 18, 2024
Panelists discuss how primary biliary cholangitis (PBC) often presents asymptomatically but can be diagnosed through elevated alkaline phosphatase levels, positive antimitochondrial antibodies, and liver biopsy when necessary.
Pharmaceutical Technology
DECEMBER 18, 2024
Industrial refrigeration is key to the healthcare industry, but it contributes massively to its emissions.
Pharmacy Times
DECEMBER 18, 2024
Panelists discuss how ursodeoxycholic acid is the first-line treatment for primary biliary cholangitis (PBC), with early initiation being crucial for optimal outcomes and prevention of disease progression.
Pharmaceutical Technology
DECEMBER 18, 2024
A new report identifies data content management as the primary driver of growth in the pharmaceuticals market.
pharmaphorum
DECEMBER 18, 2024
Sensorion's gene therapy for otoferlin-related hearing loss has shown early signs of improving hearing in two toddlers in a phase 1/2 trial.
Pharmaceutical Technology
DECEMBER 18, 2024
Gilead Sciences has entered a strategic partnership with Terray for the discovery and development of small-molecule therapies.
pharmaphorum
DECEMBER 18, 2024
Luigi Mangione has been charged with first-degree murder "in furtherance of terrorism" in connection with the death of the UnitedHealth CEO
Pharmaceutical Technology
DECEMBER 18, 2024
Improper advertising on media constituted a large part of traffic directed to the companies websites.
Fierce Healthcare
DECEMBER 18, 2024
Tech platform Uno Health is rolling out a self-service guide that shows users financial savings they could be eligible to obtain. | Uno Health wants to make it easier for individuals to access programs like Medicare, Medicaid and SNAP to reduce costly bills.
Pharmaceutical Technology
DECEMBER 18, 2024
Picking the right clinical partners will be critical for oncology innovators hoping to stay up to speed in a rapidly changing industry.
Fierce Healthcare
DECEMBER 18, 2024
Taking a look at funding trends in 2024 gives a strong sense of where investors are placing their bets in health tech. | Fierce Healthcare collaborated with SignalFire, an early-stage venture capital firm, to compile a data-backed list of the fastest-growing health tech startups, based on 2024 funding, as well as the companies that have pocketed the most total funding in the past decade.
Let's personalize your content